ArticleHIV/AIDS (Auckland, N.Z.)2024

Switching to Dolutegravir/Lamivudine Two-Drug Regimen: Durability and Virologic Outcomes by Age, Sex, and Race in Routine US Clinical Care.

Gerald Pierone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.